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a b s t r a c t
Peste des petits ruminants (PPR) is an important economically transboundary disease of sheep and goats
caused by a virus which belongs to the genus Morbillivirus. This genus, in the family Paramyxoviridae,
also includes the measles virus (MV), canine distemper virus (CDV), rinderpest virus (RPV), and marine
mammal viruses. One of the main features of these viruses is the severe transient lymphopaenia and
immunosuppression they induce in their respective hosts, thereby favouring secondary bacterial and
parasitic infections. This lymphopaenia is probably accounted for by the fact that lymphoid cells are theorbillivirus
aramyxoviridae
PRV
LAM
mmunosuppression
main targetsof themorbilliviruses. Inearly2000, itwasdemonstrated that a transmembraneglycoprotein
of the immunoglobulin superfamily which is present on the surface of lymphoid cells, the signalling
lymphocyte activation molecule (SLAM), is used as cellular receptor by MV, CDV and RPV. Wild-type
strains of these viruses can be isolated and propagated efﬁciently in non-lymphoid cells expressing this
protein. The present study has demonstrated thatmonkey CV1 cells expressing goat SLAMare also highly
V fro
lso aymphopaenia efﬁcient for isolating PPR
for MV, CDV and RPV, is a
. Introduction
Peste des petits ruminants (PPR) is a highly contagious viral dis-
ase of sheep, goats and wild small ruminants (Abu Elzein et al.,
004; Furley et al., 1987; Lefèvre and Diallo, 1990). PPR is a trans-
oundary animal disease causing signiﬁcant economic lossesdue to
ts high morbidity and mortality, and has therefore been classiﬁed
mong diseases that must be notiﬁed to the World Organisation
or Animal Health (OIE). It poses a serious threat to the develop-
ent of small ruminant production in all areas where it occurs,
amely Africa, the Middle East and Asia. As poor people in devel-
ping countries rely on small ruminants, particularly goats, for their
ivelihoods, it has been suggested that the control of PPR in endemic
egions should be reﬂected in developing poverty alleviation poli-
∗ Corresponding author. Tel.: +43 1260028355; fax: +43 1260028222.
E-mail address: adama.diallo@iaea.org (A. Diallo).
166-0934/  2011 Elsevier B.V. Open access under CC BY license.
oi:10.1016/j.jviromet.2011.02.024
©m pathological samples. This ﬁnding suggests that SLAM, as is in the case
receptor for PPRV.
© 2011 Elsevier B.V. Open access under CC BY license.
cies (Perry et al., 2002). Clinically, PPR is characterized by pyrexia,
necrotic stomatitis, catarrhal inﬂammation of the ocular and nasal
mucosae, bronchopneumonia, diarrhoea and, inmany cases, death.
Apart from the bronchopneumonia, all these clinical signs resem-
ble those of rinderpest, the cattle plague. The causal agents of
both diseases are closely related viruses, peste des petits ruminants
virus (PPRV) and rinderpest virus (RPV). They are classiﬁed in the
genus Morbillivirus within the family Paramyxoviridae (Gibbs et al.,
1979). Other members of this genus include measles virus (MV),
a serious human pathogen, canine distemper virus (CDV) affect-
ing animals of the family Canidae, phocine distemper virus (PDV)
and cetaceanmorbilliviruses (CMV)which affectmarinemammals.
All these viruses induce in their respective hosts a transient but
severe immunosuppression which favours secondary opportunis-
tic bacterial and parasitic infections responsible for many of the
disease symptoms and the severity of the infection (Obi et al.,
1983; Seki et al., 2003; Ugochukwu and Agwu, 1991). It is likely
that several mechanisms contribute to this morbillivirus-induced
ologic
i
d
S
m
T
t
(
t
1
S
2
b
r
t
o
e
2
t
t
2
t
I
s
m
L
1
i
c
u
f
(
o
t
f
w
(
2
u
2
e
a
b
T
i
i
s
2
2
r
M
a
s
1
m
t
(
2
tC.M. Adombi et al. / Journal of Vir
mmunosuppression including leucopaenia, a major sign observed
uring infection (Heaney et al., 2002; Rajak et al., 2005; Schneider-
chaulies et al., 2001) since lymphoid cells are a major target of
orbilliviruses (Takeda et al., 2007; Wohlsein et al., 1993, 1995).
his tropism is linked to the presence of a protein receptor on
he cell surface, the signalling lymphocyte activation molecule
SLAM) also known as CD150 which is used preferentially by wild-
ype morbilliviruses to bind to the host (Baron, 2005; Cocks et al.,
995; Kruse et al., 2001; McQuaid & Cosby, 2002; Ono et al., 2001;
idorenko and Clark, 1993; Tatsuo et al., 2000, 2001; Yanagi et al.,
006). However, although lymphoid tissues are major sites of mor-
illivirus replication, it is also observed that they can infect and
eplicate in epithelial cells of other organs such as the alimentary
rack epithelial cells; lung and kidney cells by utilising other types
f cell receptors that have yet to be clearly identiﬁed (Hashimoto
t al., 2002; Leonard et al., 2008; Plowright, 1964; Tahara et al.,
008; Takeuchi et al., 2003; Wohlsein et al., 1993, 1995). The infec-
ion efﬁciency for those cells is up to 100–1000 times less than
hat of the lymphoid cells (Hashimoto et al., 2002; Takeda et al.,
007), but because they are easy to maintain in culture in vitro,
hey have been favoured preferentially for morbillivirus isolation.
n the case of PPRV, primary cultures of bovine kidney, goat kidney,
heep kidney and lung cells have all been utilised for isolation and
aintenance (Abu Elzein et al., 1990; El Hag Ali and Taylor, 1984;
efèvre and Diallo, 1990; Taylor et al., 1990; Taylor and Abegunde,
979). However not only is the availability of primary cells becom-
ng more problematic their quality is not guaranteed and there is
onsiderable variation from batch to batch. These drawbacks in the
se of primary cell cultures have stimulated the use of cell lines
or PPRV isolation, in particular the African green monkey kidney
Vero) cell line (Lefèvre and Diallo, 1990). Unfortunately, as with
thermorbilliviruses, PPRV isolation using these cells is inefﬁcient:
he likelihood of isolating the virus is very low and even if success-
ul it often requires multiple, sequential blind passages and many
eeks in culture before the development of any cytopathic effect
CPE) can be observed (Abu Elzein et al., 1990; Albayrak and Alkan,
009; Gulyaz and Ozkul, 2005; Lefèvre and Diallo, 1990).
Following the identiﬁcation of the SLAM as the main receptor
sed by MV, CDV and RPV wild type strains (Baron, 2005; Hsu et al.,
001; Ono et al., 2001; Tatsuo et al., 2000, 2001), Vero or CHO cells
xpressing human, dog or bovine SLAM proteins have been used as
highly efﬁcient means of isolation and propagation of these mor-
illiviruses (Ono et al., 2001; Seki et al., 2003; Tatsuo et al., 2001).
hispaper reports thedevelopmentof aCV1cell line stablyexpress-
ng the goat SLAM protein. This new cell line, designated CHS-20,
s highly efﬁcient for isolating wild type PPRV from pathological
pecimens.
. Materials and methods
.1. Cell lines and culture
Flp-In-CV-1 cells, referred to as CV1,were purchased from Invit-
ogen (Eugene, Oregon, USA). They were grown in the Dulbecco’s
odiﬁed Eagle Medium (DMEM) supplemented with 10% irradi-
ted foetal calf serum (FCS) and 1% mixed antibiotic–antimycotic
olution (Invitrogen, Eugene, Oregon, USA), 2mM l-glutamine,
mM sodium pyruvate, and 100g/ml zeocin. The African green
onkey kidney cells (Vero) were grown in DMEM medium con-
aining 10% FCS and 1% mixed antibiotic–antimycotic solution
Invitrogen, Eugene, Oregon, USA)..2. Goat SLAM cDNA cloning
A cDNA sequence corresponding to open reading frame of
he goat SLAM that was available in Genbank (Accession No.al Methods 173 (2011) 306–313 307
DQ228869) was synthesized and cloned into pUC57 vector by
GenScript (Piscataway, NJ, USA). The cDNA was removed from
the plasmid and sub-cloned into pcDNA5/FRT plasmid (Invitro-
gen, Eugene, Oregon, USA). The new plasmid, pFRT-CHS-20, was
ampliﬁed in Escherichia coli DH5alpha bacteria, puriﬁed with the
Endo-Free Plasmid Maxi Kit (Qiagen, Hilden, Germany) and used to
transfect the cells.
2.3. Cells stably expressing goat SLAM
The pFRT-CHS-20 plasmid was used to transfect the CV1cells
of the Flp-In system according to the manufacturer’s instructions
(Invitrogen, Eugene, Oregon, USA). Cells which had incorpo-
rated the recombinant plasmid were selected in a medium
composed of the DMEM (Invitrogen, Eugene, Oregon, USA) sup-
plemented with 10% FCS and the antibiotic hygromycin at a
ﬁnal concentration of 600g/ml. The cell clones which were
resistant to this antibiotic were picked up and expanded in the
selecting medium. The cloned cells were each cultured individ-
ually in a 25 cm2 ﬂask and after 10 passages, total RNA was
extracted for each clone using the RNAeasy mini kit (Qiagen,
Hilden, Germany). From this total RNA, mRNAs were puriﬁed
using the Oligotex mRNA kit (Qiagen, Hilden, Germany) and sub-
mitted to RT-PCR ampliﬁcation using the following goat SLAM
primers: Slam-BCO273F (5′aagagcaggaaggaggatgaagg3′) and Slam-
BCO273R (5′gccaagagtgagatacaagaggtg3′). Brieﬂy, 8l of each RNA
was reverse transcribed (RT) into cDNAusing the First Strand cDNA
Synthesis kit (GE Healthcare, Buckinghamshire, UK) according to
themanufacturer’s instructions and using the randomprimers pdN
(6). Five l of the cDNA was obtained were used for the detec-
tion of goat SLAM mRNA by PCR with the goat SLAM primers
indicated above. As a control for the quality of the extracted
mRNA, a further ﬁve l of the same cDNA was submitted to PCR
to amplify mRNA corresponding to the -actin gene by using
the speciﬁc primers Bact1 (5′accaactgggacgacatggaga3′) and Bact2
(5′agccatctcctgctcgaagtc3′).
2.4. Viruses and clinical specimens
In this study, the live attenuated PPRV Nigeria 75/1 vaccine
strain was used. This virus was isolated originally from a sick goat
on primary lamb kidney cell culture in Nigeria and attenuated
by serial passages on Vero cells (Diallo et al., 1989; Taylor and
Abegunde, 1979). In addition, clinical specimens from sick sheep
and goats with suspected PPR were collected in 2008 and 2009
from different locations in Nigeria and Côte d’Ivoire respectively.
The details of the samples are summarized in Table 1.
2.5. PPRV identiﬁcation by RT-PCR and quantitative RT-PCR
(RT-qPCR)
Before attempting isolation of the PPRV from the suspected
infected pathological specimens used in this study, they were ﬁrst
screened by the reverse transcriptase polymerase chain reaction
(RT-PCR) assay for the detection of viral nucleic acid. An RNeasy
mini kit (Qiagen, Hilden, Germany) was used to extract total RNA
from these specimens. RNAs were also extracted from cell culture
medium to detect the presence of virus by RT-PCR.
These extracted RNAs were then submitted to the ampliﬁcation
of the PPRV RNA by the classical RT-PCR as described previously by
Couacy-Hymann et al. (2002). The ampliﬁed cDNA samples were
analysed by electrophoresis in 1.5% agarose gel stained with ethid-
ium bromide at a concentration of 1g/ml.
The RNA samples that were extracted from the pathologi-
cal samples were analysed by the one-step reverse transcription
quantitative real-time PCR (RT-qPCR) using the iScript One-Step
308 C.M. Adombi et al. / Journal of Virological Methods 173 (2011) 306–313
Table 1
Detail of the 68 clinical tissue specimens used in this study: 56 samples were collected in 2008 in Nigeria and 12 were collected in Côte d’Ivoire in 2009.
Sample ID Tissue Animal species Month/year Location Country
NIG/08-01 Lymph node Caprine Unknown Kaduna Nigeria
NIG/08-02 Spleen Caprine Unknown Kaduna Nigeria
NIG/08-03 Lung Caprine Unknown Kaduna Nigeria
NIG/08-04 Lymph node Caprine Unknown Kaduna Nigeria
NIG/08-05 Spleen Caprine Unknown Kaduna Nigeria
NIG/08-06 Lung Caprine Unknown Kaduna Nigeria
NIG/08-07 Spleen Caprine Unknown Kaduna Nigeria
NIG/08-08 Lung Caprine Unknown Kaduna Nigeria
NIG/08-09 Lung Caprine 5/08 Nsukka Nigeria
NIG/08-10 Lymph node Ovine 5/08 Nsukka Nigeria
NIG/08-11 Spleen Ovine 5/08 Nsukka Nigeria
NIG/08-12 Lung Ovine 5/08 Nsukka Nigeria
NIG/08-13 Liver Ovine 5/08 Nsukka Nigeria
NIG/08-14 Lymph node Caprine 5/08 Nsukka Nigeria
NIG/08-15 Spleen Caprine 5/08 Nsukka Nigeria
NIG/08-16 Lung Caprine 6/08 Jos Nigeria
NIG/08-17 Lung Caprine 8/08 Eket Nigeria
NIG/08-18 Spleen Caprine 8/08 Eket Nigeria
NIG/08-19 Lung Caprine 5/08 Nsukka Nigeria
NIG/08-20 Liver Caprine 5/08 Nsukka Nigeria
NIG/08-21 Spleen Caprine 5/08 Nsukka Nigeria
NIG/08-22 Spleen Caprine 6/08 Jos Nigeria
NIG/08-23 Liver Caprine 6/08 Jos Nigeria
NIG/08-24 Lung Caprine 9/08 Misau Nigeria
NIG/08-25 Spleen Caprine 9/08 Misau Nigeria
NIG/08-26 Lymph node Caprine 9/08 Misau Nigeria
NIG/08-27 Lung Caprine 5/08 Zaria Nigeria
NIG/08-28 Liver Caprine 5/08 Zaria Nigeria
NIG/08-29 Spleen Caprine 5/08 Zaria Nigeria
NIG/08-30 Lymph node Caprine 5/08 Zaria Nigeria
NIG/08-31 Lymph node Ovine 7/08 Vom Nigeria
NIG/08-32 Lymph node Ovine 7/08 Vom Nigeria
NIG/08-33 Trachea Ovine 7/08 Vom Nigeria
NIG/08-34 Lung Ovine 7/08 Vom Nigeria
NIG/08-35 Lung Ovine 7/08 Vom Nigeria
NIG/08-36 Trachea Ovine 7/08 Vom Nigeria
NIG/08-37 Lung Caprine 6/08 Jos Nigeria
NIG/08-38 Spleen Caprine 6/08 Jos Nigeria
NIG/08-39 Lung Caprine 6/08 Ilesha Nigeria
NIG/08-40 Spleen Caprine 6/08 Ilesha Nigeria
NIG/08-41 Spleen Caprine 8/08 Azare Nigeria
NIG/08-42 Lung Caprine 8/08 Azare Nigeria
NIG/08-43 Lung Caprine 5/08 Zaria Nigeria
NIG/08-44 Liver Caprine 5/08 Zaria Nigeria
NIG/08-45 Spleen Caprine 8/08 Kebbi Nigeria
NIG/08-46 Lymph node Caprine 8/08 Kebbi Nigeria
NIG/08-47 Lung Caprine 8/08 Kebbi Nigeria
NIG/08-48 Lung Caprine 8/08 Kebbi Nigeria
NIG/08-49 Spleen Caprine 8/08 Sokoto Nigeria
NIG/08-50 Lymph node Caprine 8/08 Sokoto Nigeria
NIG/08-51 Lung Caprine 8/08 Sokoto Nigeria
NIG/08-52 Lung Caprine 8/08 Kebbi Nigeria
NIG/08-53 Spleen Caprine 8/08 Kebbi Nigeria
NIG/08-54 Lymph node Caprine 8/08 Kebbi Nigeria
NIG/08-55 Spleen Caprine 8/08 Sokoto Nigeria
NIG/08-56 Lymph node Caprine 8/08 Sokoto Nigeria
CIV/09-OVP Lung Ovine 7/09 Fronobo Côte d’Ivoire
CIV/09-OVG Lymph node Ovine 7/09 Fronobo Côte d’Ivoire
CIV/09-OVF Liver Ovine 7/09 Fronobo Côte d’Ivoire
CIV/09-OVR Spleen Ovine 7/09 Fronobo Côte d’Ivoire
CIV/09-01P Lung Caprine 7/09 Amonkro Côte d’Ivoire
CIV/09-01G Lymph node Caprine 7/09 Amonkro Côte d’Ivoire
CIV/09-01F Liver Caprine 7/09 Amonkro Côte d’Ivoire
CIV/09-01R Spleen Caprine 7/09 Amonkro Côte d’Ivoire
R
s
t
U
aCIV/09-02P Lung Caprine
CIV/09-02F Liver Caprine
CIV/09-02R Spleen Caprine
CIV/09-02N Kidney CaprineT-PCR Kit (BioRad, Hercules, CA, USA) The primers and probe,
peciﬁc to PPRV nucleocapsid protein gene, were designed using
he Allele ID 6 (Premier Biosoft International, Palo Alto, CA,
SA). The primers PPRN-MGBTaqF1 (5′-ggactgggcctcgacagg-3′)
nd PPRN-MGBTaqR1 (5′-ggatcgcagctttgacttcttc-3′) were used in7/09 Amonkro Côte d’Ivoire
7/09 Amonkro Côte d’Ivoire
7/09 Amonkro Côte d’Ivoire
7/09 Amonkro Côte d’Ivoirecombination with the minor groove binder (MGB) Taqman probe
PPRN-MGBTaq01 (FAM-5′tccttcctccagcataa3′-BHQ1). The reaction
mixture, in a total volume of 20l, was made with 10l of the 2×
RT-PCR reaction mix for probes, 400nM of each primer, 200nM of
the probe and 0.4l of the iScript reverse transcriptase for one-
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tep RT-PCR, 2l of template. It was performed in hard shell PCR
lates, 96-well WHT/CLR covered with the microseal “B” ﬁlm (Bio-
ad, Hercules, CA, USA). The samples were tested in duplicate and
he reactionwasperformedusing aCFX96Real-TimePCRDetection
ystem (BioRad,Hercules, CA, USA) under the following conditions:
0 ◦C for 10min; 95 ◦C for 5min and 40 cycles of 95 ◦C for 10 s and
0 ◦C for 30 s.
.6. Virus isolation
Before using the CHS-20 cells to isolate PPRV from the suspected
PR infected pathological samples, they were ﬁrst tested with the
ive attenuated PPRV Nigeria 75/1 vaccine strain. The cells were
nfected in a 25 cm2 tissue culture ﬂask with 0.5ml of a virus sus-
ension diluted to produce a titre of 2×104 TCID50/ml. As controls,
ero andCV1 cellswere also infected in a similarway to the CHS-20
ells. The virus was allowed to adsorb on the cells at 37 ◦C for one
ourwith gentle shaking every15min. After this time, theﬂaskwas
lled with 5ml of the complete cell culture medium and returned
o the incubator at 37 ◦C. It was examined daily by phase contrast
icroscopy.
The CHS-20 cells were compared with the Vero and CV1cells to
etermine their efﬁciency in the isolation of PPRV from the patho-
ogical tissue samples. The samples were minced and ground with
terile sand using a mortar and pestle to give a 10% suspension
n serum-free DMEM media. The suspensions were clariﬁed by
ow speed centrifugation. For virus isolation, 0.5ml of the sample
omogenate was allowed to adsorb for one hour at 37 ◦C onto the
ell monolayer at 80% of conﬂuence in 25 cm2 tissue culture ﬂasks
ith shaking every 15min for one hour. After this time, 5ml of
ell growth medium supplemented with 2% antibiotics was added
o the ﬂask and it was returned to the incubator. One day after
nfection, the cell supernatant was removed and replaced by 5ml
f fresh growth medium containing 2% antibiotics. The cells were
xamined daily by microscopic observation for the detection of the
irus CPE. The cell culture medium was changed every 2 days, the
oncentration of the antibiotics being reduced to 1% from day 4
nwards. At each medium change, an aliquot of 200l was kept
or RNA extraction and detection of PPRV speciﬁc nucleic acid by
lassical RT-PCR. Cells in ﬂasks where no CPE was detected after
days of incubation were trypsinised for a blind passage. An RNA
xtract was prepared from an aliquot of these trypsinised cells for
se in an RT-PCR to detect PPRV speciﬁc nucleic acid. This cell blind
assage was repeated every week on 3 more occasions. The virus
solation was considered negative if no CPE was detected after the
ourth blind passage. However in 2 cases, up to 12 blind passages
ere made.
. Results
.1. Establishment of a CV-1 cell clone stably expressing
heep–goat SLAM
The pFRT-CHS-20 construct which comprises the pcDNA5/FRT
lasmid into which was cloned the goat SLAM cDNA was used to
ransfect the CV1 cells as described in Section 2. Five cell clones,
esistant to the selective antibiotic, were identiﬁed, picked up and
xpanded. In a subsequent step to characterize these cells, an
mmunoﬂuorescence assay was performed using the mAb IPO-3
nti-humanSLAMbut it failed todetect expressionof thegoat SLAM
rotein (result not shown). This mAb, which recognizes the human
LAM, does not react with bovine or canine SLAM (Tatsuo et al.,
001). In order to testwhether or not the selected cellswere poten-
ially producing the goat SLAM, another approach was used: the
etection of mRNA corresponding to the transcription of the goatal Methods 173 (2011) 306–313 309
SLAM gene. In this case, mRNAs were puriﬁed from the selected
antibiotic resistant cells and submitted to the RT-PCR using the
goat SLAM primers. Another ampliﬁcation was done from the same
mRNA samples using primers speciﬁc to the gene of a ubiquitous
protein, -actin, to evaluate the quality of the puriﬁed extracted
mRNA. As shown in Fig. 1, while all ﬁve clones were positive for the
-actin mRNA (Fig. 1A), only 2 were positive for the presence of the
goat SLAM mRNA (Fig. 1B). A PCR test performed on an aliquot of
the extracted mRNA without the RT step remained negative (result
not shown), proof that the SLAMpositive result from the two clones
was not due to contamination from the plasmid used to transfect
the cellsnor fromthecell genomicDNA.Oneof the cell cloneswhich
contained the goat SLAM mRNA, CHS-20, was selected and used for
the rest of the study.
3.2. Identiﬁcation of PPRV in pathological samples by classical
and quantitative RT-PCR
Fifty six and 12 PPR suspected pathological tissue samples that
were collected in 2008 and 2009 respectively in Nigeria and Côte
d’Ivoire (Table 1) were analysed by both classical and quantitative
RT-PCR using speciﬁc PPRV primers targeting the virus nucleo-
capsid protein (Np) gene. Twenty three of the 68 samples that
were analysed were positive by the classical RT-PCR assay while
the quantitative RT-PCR detected 3 more positive samples, 2 from
lymph nodes and 1 from spleen. The results are summarized in
Table 2. All 26 samples that tested PPR positive by these assays
were submitted to the PPRV isolation trial on cell culture.
3.3. Use of CV1 cells expressing the goat SLAM protein, CHS-20
cells, to isolate PPRV from positive pathological samples
Before using the CHS-20 cells to isolate PPRV from the patho-
logical samples, they were ﬁrst tested with the live vaccine PPRV
Nigeria 75/1 strain which has been attenuated by serial passages
on Vero cells (Diallo et al., 1989). One day after infection, syncytia
were detected in many places in the ﬂask containing the infected
CHS-20 cells (Fig. 2B) but no modiﬁcation was observed in the non-
infected control CHS-20 cells (Fig. 2A). By day 2 the syncytia had
enlarged so much that many of them had fused. By day 3 many
cells had detached from the layer. The ﬂask was then frozen and
stored at −80 ◦C. In the Vero and CV1 cells, the CPE was slightly
discernible only at day 3 post infection. It was characterized by the
appearance of rounded, refringent cells that were clumped into
grape-like clusters (not shown). They became detached from the
cell layer without showing giant cells. At day 7 post infection, the
CPEwasmore advanced and those ﬂaskswere also stored at −80 ◦C
in the deep freezer, as with the previous ﬂask.
Following this preliminary test which demonstrated that the
Vero cell-adapted PPRV vaccine Nigeria 75/1 strain caused the
formation of syncytia in the CHS-20 cells but not in the Vero or
the CV1cells, the efﬁcacy of the SLAM-modiﬁed cells for isolating
PPRV from the 26 pathological specimens that had been identiﬁed
PPRV positive by the nucleic acid ampliﬁcation assayswas assessed
(Table 2). The CV1 and Vero cells were also included in the isolation
trial. In CHS-20 cell culture a CPEwas detected fromday 1 to day 10
after infection and without any subsequent blind passage. In a sim-
ilar manner to the effects seen with the live vaccine strain, it was
characterized by the appearance of vacuolated syncytia (Fig. 2C and
D) in the cell monolayer while no CPE was observed in the control
cells (Fig. 2A). The syncytia increased in size in 2–3 days to form
large cell clumps that detached from the cell layer. The ﬂask was
frozen when the CPE covered about 70–80% of the cell layer. Out
of the 26 samples that were used in this trial, the virus isolation on
CHS-20 cellswas successfulwith 16. In the case of the CV1 andVero
cells, no CPE could be detected after 4 blind passages. The cell cul-
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Nig. 1. Photographs of the RT-PCR results to identify the cell clones potentially exp
B) amplicons corresponding to the RT-PCR of the goat SLAM mRNA. Lane M, 100
lasmid; lane 1A, transfected selected clone 1; lane 2B, transfected selected clone
ransfected selected clone 5.
ure supernatants were collected regularly and tested by RT-PCR to
etect the eventual release of virus in the medium as indicated in
ection 2. An aliquot of the cellswas also collected at the time of the
lind passage and tested for the presence of the PPRV RNA. While
he release of the virus in the infected cell culture supernatant was
ffectively demonstrated for the 16 samples which had developed
able 2
esults of the PPRV isolation trial on cell culture from the pathological specimens that we
ere used in this trial.
Tissue Sample ID PPRV RT-PCR
result on tissue
sample
Virus isola
CHS-20
Lung
NIG/08-03 + 3 days
NIG/08-17 + 8 days
NIG/08-27 + 2 days
NIG/08-43 + 2 days
CIV/09-OVP + N
CIV/09-01P + 1 day
CIV/09-02P + 2 days
Lymph node
NIG/08-04 +d N
NIG/08-10 +d 7 days
NIG/08-30 + 3 days
CIV/09-OVG + N
CIV/09-01G + 2 days
Liver
NIG/08-20 + N
NIG/08-28 + 5 days
NIG/08-44 + 8 days
CIV/09-OVF + N
CIV/09-01F + N
CIV/09-02F + 4 days
Spleen
NIG/08-11 +d 10 days
NIG/08-18 + 10 days
NIG/08-22 + 8 days
NIG/08-29 + 7 days
CIV/09-OVR + N
CIV/09-01R + N
CIV/09-02R + N
Kidney CIV/09-02N + N
=no CPE. Samples in bold were used in the RT-PCR shown in Fig. 3.
a Day post infection (dpi) on which the CPE was detected in the cell monolayer.
b Up to 4 blind passages were performed.
c Positive for the RNAs that were extracted from the cells at the time of the ﬁrst blind p
d Positive in real time PCR only.g the goat SLAM: (A) amplicons corresponding to the RT-PCR of the -actin mRNA;
A molecular weight ladder; lane C−, control cells non-transfected with the SLAM
e 3C, transfected selected clone 3; lane 4D, transfected selected clone 4; lane 5E,
syncytia in the CHS-20 cells, virus could not be detected in the cell
culture supernatant medium for the 10 remaining samples that did
not develop CPE (data not shown). Fig. 3 details the efﬁciency of
the three cells lines (Vero, CV1 and CHS-20) in isolating PPRV from
lung, lymph node, spleen and liver collected from the same ani-
mal from Côte d’Ivoire. As of days 2 and 4, PPRV RNA is detected
re tested PPRV positive by classical and quantitative RT-PCR. CHS-20, CV1 and Vero
tiona Detection of PPRV in cell culture
supernatant (RT-PCR)
CV1b Verob CHS-20 CV1 Vero
N N + − −
N N + − −
N N + − −
N N + + +
N N − − −
N N + + −c
N N + − −
N N − − −
N N + − −
N N + − −
N N − − −
N N + −c −
N N − − −
N N + − −
N N + − −
N N − − −
N N − − −
N N + − −
N N + − −
N N + − −
N N + − −
N N + − −
N N − − −
N N − − −
N N − − −
N N − − −
assage.
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Fig. 2. Photographs of the microscopic observation of the CHS-20 cells: (A) non infected cells, (B) cells infected with the attenuated PPRV Nigeria 75/1 (1 day post infection),
(C) cells infected with the pathological specimen NIG/08-43 (2 days post infection), and (D) cells infected with the pathological sample CIV/09-01P (2 days post infection).
Some of the syncytia are shown by the arrows.
Fig. 3. Monitoring the efﬁciency of CHS-20, CV1 andVero cell lines in isolating PPRV frompathological specimens (lung, lymphnode, spleen and liver) collected from the same
animal: gel electrophoresis photograph of DNA ampliﬁed by RT-PCR of RNA extracted from different samples: 1 = supernatant at day 2 post infection; 2 = supernatant at day 4
post infection; 3 = supernatant at day 8 post infection; 4 = cells collected after trypsination at day 8 post infection; −=negative control; + =positive control; −C1=non-infected
CHS20 cells; −C2=non-infected CV1 cells; −C3=non-infected Vero cells.
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ffectively in the supernatant of CHS-20 cells infectedwith the lung
CIV/09-01P)and lymphnode (CIV/09-01G) specimens respectively
supernatants from day 1 were not tested). The CPE was visible in
hese cells at days 1 and 2 respectively (Table 2). In contrast, in
he CHS-20 cells that were infected with specimens from the liver
nd the spleen, all samples remained negative by RT-PCR and no
PE could be detected. For the other cell types, PPRV RNA could
e clearly detected in all samples, supernatants and cells, collected
rom only CV1 cells infected with the lung specimen (CV1/09-01P).
or CV1 and Vero cells infected with CIV/09-01G and CIV/09-01P
espectively, only the collected cell samples were clearly positive
y RT-PCR. All other samples were negative. No CPE was seen in
he infected CV1 and Vero cells that were positive by RT-PCR at the
ime of sample collection. The results obtained for all the samples
hat were tested are summarized in Table 2. In the CHS-20 cells,
he CPE was detected at days 1 and 2 post infection for the lung and
he lymph node specimen respectively. Since Vero cells are often
sed for PPRV isolation, those cells thatwere infectedwith the lung
amples CIV/09-01P and NIG/08-43, and in which the virus was
etected (Table 2), were submitted to more weekly blind passages.
t was necessary to continue to sub-culture the cells for 11 and 12
eekspost-infection inorder todetectCPE in theVerocells infected
ith the CIV/09-01P and NIG/08-43 (not shown) samples respec-
ively. The CPE was characterized by the appearance of rounded,
efringent cells that were clumped into grape-like clusters. They
etached from the cell layer without showing clear syncytia. After
he ﬁrst day of the appearance of the CPE, the cell culture medium
as collected every 2 days and the ﬁnal collectionwas done aweek
ater.
. Discussion
In this study a new cell line, CHS-20, was developed by insert-
ng into the genomeof themonkey cell CV1, cDNAcorresponding to
he goat SLAM protein gene. Since no anti-goat SLAM antibody was
vailable to demonstrate the production of this protein in CHS-20
ells, the RT-PCR assay was used for amplifying the mRNA cor-
esponding to the transcript of this protein gene. The infection
f these cells by the live attenuated vaccine PPRV Nigeria 75/1
esulted in the development of detectable syncytia. This viral strain
as been adapted to grow in Vero cells in which it causes a CPE
haracterized by the presence of rounded refringent cells. In these
nfected cells, very small syncytia are usually seen only after the
osin–haemalun dye-staining (Diallo, 2010; Diallo et al., 1989). In
his study, infection of the CV1 cells produced a CPE identical to
hat seen on unstained, infected Vero cells. However, in CHS-20
ells, the CV1 cell line that contains the goat SLAM gene, this atten-
ated PPRV caused the development of large syncytia, like those
btained in cells expressing human, dog or monkey SLAM infected
y MV, CDV or RPV (Erlenhoefer et al., 2001; Kobune et al., 1990,
991; Ono et al., 2001; Tatsuo et al., 2001; Seki et al., 2003; Baron,
005). Based on this result, and since the mRNA corresponding to
he transcript of the goat SLAM gene was detected in the CHS-20
ells, it is concluded that these cells are certainly expressing the
oat SLAM and that this protein could be used as a receptor by the
ero cell-adapted PPRV Nigeria 75/1. Previous studies carried out
ith MV and RPV demonstrated that the SLAM protein is not only
he main cell receptor for morbilliviruses wild-type strains but can
lso be used by the cell-adapted MV and RPV viruses for which
ther receptors have been identiﬁed, namely the ubiquitous pro-
ein CD46 protein and heparin sulphate respectively (Baron, 2005;
aniche et al., 1993; Ono et al., 2001; Seki et al., 2003). Following
he encouraging results obtained from infecting CHS-20 cells with
he attenuated PPRV Nigeria 75/1 strain, the new cells were further
valuated for their capacity to enable PPRV isolation from patho-al Methods 173 (2011) 306–313
logical specimens containingwild-type viruses. For this evaluation,
the 26 samples from small ruminant in which PPRV RNA had been
detected by classical RT-PCR and RT-qPCR were used. From many
of these samples PPRV was recovered in these CHS-20 cells with-
out any blind passage. The CPE, characterized by the appearance
of large syncytia in the cell layer, was detected for some samples
and as early as one day post-infection in one occasion. However,
with the same samples a CPE related to a virus infection could not
be detected in CV1 and Vero cells even after 4 blind passages. The
excretion of the virus into culture medium was detected by RT-
PCR in the absence of a CPE in one instance in a Vero cells, and
in two instances in the CV1 cells (Table 2). In this study as shown
in Fig. 3, the CV1 cells seem to be more sensitive than the Vero
cells for the isolation of PPRV from pathological specimens. How-
ever, and since Vero cells are used commonly for PPRV isolation
and growth, the blind passages were continued for 2 lung sample-
infected Vero cells. In these cases the infected Vero cells showed a
CPE only after 11 and 12 weeks post-infection. The same samples
produced syncytia on the CHS-20 cells within 1 and 2 days after
infection. In order to cause a visible CPE requires the presence of
adapted mutant (s) in the virus suspension which was (or were)
obtained in sufﬁcient quantities for the two samples only after 11
and 12weeks of continuous culture. In the case of CHS-20 cells, this
adaptation, probably to a receptor to enter into the host cell, was
unnecessary. Based on the results of this study it is concluded that
in addition to MV, CDV and RPV, another morbillivirus, PPRV, also
uses the SLAM protein as a receptor to infect the host cell. How-
ever, as suggested for MV, SLAM is certainly not the only protein
that can be used as a receptor by the PPRVwild-type strains (Tahara
et al., 2008; Takeda et al., 2007; Takeuchi et al., 2003). Indeed, as in
the case of MV and other morbilliviruses, histopathological studies
carried out on different tissues collected from hosts infected with
PPR has revealed the presence of the virus, as demonstrated by the
detection of syncytia, in cells such as renal, hepatic, respiratory and
alimentary tract cellswhichdonot express the SLAMprotein (Aruni
et al., 1998; Kul et al., 2007). In these cells, wild-type PPRV strains
might use an alternative receptor(s), probably less efﬁcient than
the SLAM protein, for binding the virus.
5. Conclusion
The integration of cDNA corresponding to the gene of the goat
SLAM into the CV1 monkey cell genome resulted in a cell which
expressed this protein. Infection of this cell by PPRV resulted in the
development of syncytia in a similar manner to that demonstrated
byVero cells expressing human, canine or bovine SLAMprotein and
infected by MV, CDV of RPV. Preliminary tests carried out with this
new cell line, CHS-20, have demonstrated its high sensitivity for
isolating PPRV from pathological samples. This ﬁnding will consti-
tute an important element in the future for the diagnosis of PPR by
facilitating the isolation of PPRV from pathological specimens.
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